| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/07/2001 | EP1074617A2 Primers for synthesising full-length cDNA and their use |
| 02/07/2001 | EP1074613A1 Lentivirus from the group of immunodeficiency viruses from drill apes (Mandrillus leucophaeus) and its use |
| 02/07/2001 | EP1074564A1 Substance with antithrombotic activity and method for detecting glycokallidin |
| 02/07/2001 | EP1074563A1 Chimeric polypeptides enhancing dimer formation through electrostatic interactions and disulfide bond, method for production and uses thereof |
| 02/07/2001 | EP1074562A1 Monoclonal antibody directed against the thrombin-antithrombin III complex and its use in immunoassays |
| 02/07/2001 | EP1074561A2 Analogues of lipopolysaccharide-binding protein (LBP)-derived peptides |
| 02/07/2001 | EP1074560A2 Crude extract from viscum album coloratum, and proteins and lectins isolated therefrom |
| 02/07/2001 | EP1074559A1 Peptide nucleic acids |
| 02/07/2001 | EP1074266A2 Live attenuated bacteria for use in a vaccine |
| 02/07/2001 | EP1074264A1 Neovascularization inhibitors |
| 02/07/2001 | EP1073905A1 Methods of selecting internalizing antibodies |
| 02/07/2001 | EP1073899A1 Improved method for purifying cholera toxin |
| 02/07/2001 | EP1073763A1 Methods for transducing fusion molecules |
| 02/07/2001 | EP1073759A1 Recombinant virus expressing foreign dna encoding feline cd80, feline cd28, feline ctla-4 or feline cd86 and uses thereof |
| 02/07/2001 | EP1073758A1 Retroviral vectors including modified envelope escort proteins |
| 02/07/2001 | EP1073755A2 Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein |
| 02/07/2001 | EP1073751A2 Polypeptide with immunogenic properties and with a protein with modified biological functions |
| 02/07/2001 | EP1073750A1 Preparation of human papillomavirus e1 having helicase activity and method therefor |
| 02/07/2001 | EP1073748A2 Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis |
| 02/07/2001 | EP1073747A1 Basb013 dna and proteins from neisseria meningitidis |
| 02/07/2001 | EP1073746A2 Bacterial yjeq polypeptide family |
| 02/07/2001 | EP1073745A2 Immunization against and treatment for infection by h. pylori |
| 02/07/2001 | EP1073744A1 Multifunctional adhesin proteins and their display in microbial cells |
| 02/07/2001 | EP1073743A1 Flowering locus t (ft) and genetically modified plants having modulated flower development |
| 02/07/2001 | EP1073742A2 Human nucleic acid sequences of bladder tumour tissue |
| 02/07/2001 | EP1073741A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 02/07/2001 | EP1073740A1 Polynucleotides isolated from skin cells and methods for their use |
| 02/07/2001 | EP1073739A2 Cd40-interacting and traf-interacting proteins |
| 02/07/2001 | EP1073738A2 Human k+ ion channel and therapeutic applications thereof |
| 02/07/2001 | EP1073737A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 02/07/2001 | EP1073736A1 Delayed rectifier potassium channel subunit |
| 02/07/2001 | EP1073735A1 Host-encoded protein expressed on marek's disease virus (mdv)-infected cells and antibody thereto |
| 02/07/2001 | EP1073734A2 Tumor associated nucleic acids and uses therefor |
| 02/07/2001 | EP1073733A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY |
| 02/07/2001 | EP1073727A2 Human nucleic acid sequences from ovarian tumour tissue |
| 02/07/2001 | EP1073721A1 Efficient purification of adenovirus |
| 02/07/2001 | EP1073718A1 Nucleic acids that control seed and fruit development in plants |
| 02/07/2001 | EP1073717A1 Methods of screening for agonists and antagonists of the interaction between the human kiaa0001 receptor and ligands thereof |
| 02/07/2001 | EP1073715A1 Methionin containing animal cell culture medium and its use |
| 02/07/2001 | EP1073710A2 Non-stochastic generation of genetic vaccines and enzymes |
| 02/07/2001 | EP1073683A1 G-csf receptor agonist antibodies and screening method therefor |
| 02/07/2001 | EP1073681A1 Cloning of a novel 7tm receptor axor-2 |
| 02/07/2001 | EP1073680A1 Protein mixtures to induce therapeutic angiogenesis |
| 02/07/2001 | EP1073679A1 Peptide fragments of murine epidermal growth factor as laminin receptor targets |
| 02/07/2001 | EP1073678A1 Peptide with endotoxin-neutralizing activity |
| 02/07/2001 | EP1073676A1 Immunodiagnostic reagent for the detection of maedi-visna virus and caev infection |
| 02/07/2001 | EP1073671A1 Targeted gene delivery to cells by filamentous bacteriophage |
| 02/07/2001 | EP1073670A1 Optimization of pest resistance genes using dna shuffling |
| 02/07/2001 | EP1073669A2 Gcp |
| 02/07/2001 | EP1073668A2 Solution phase biopolymer synthesis |
| 02/07/2001 | EP1073465A1 T cell inhibitory receptor compositions and uses thereof |
| 02/07/2001 | EP1073461A1 Viral chimeras comprised of caev and hiv-1 genetic elements |
| 02/07/2001 | EP1073458A1 Chlamydia proteins and their uses |
| 02/07/2001 | EP1073457A1 Modifications of antigens by the introduction of aldehyde groups and their use in enhancing the immune response |
| 02/07/2001 | EP1073456A1 Compositions and methods for the prevention and treatment of cardiovascular diseases |
| 02/07/2001 | EP1073452A2 Method for treating cytokine mediated hepatic injury |
| 02/07/2001 | EP1073450A1 PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR |
| 02/07/2001 | EP1033997A4 Method of mobilizing hematopoietic stem cells |
| 02/07/2001 | EP0943096A4 A PROTEIN PREPARATION THAT MEDIATES Ca2+ -DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF |
| 02/07/2001 | EP0720621B1 Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
| 02/07/2001 | EP0562025B1 Compounds and their use in a binary synthesis strategy |
| 02/07/2001 | EP0559769B1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 02/07/2001 | EP0462207B1 T-pa mutants resistant to inhibition by their cognate inhibitors |
| 02/07/2001 | CN1283229A Promoter from ashbya gossypii |
| 02/07/2001 | CN1283228A Polypeptide, their production method and use |
| 02/07/2001 | CN1283202A Troponic CI complexes |
| 02/07/2001 | CN1283121A HIV-ITAT or derwatives thereof for prophylatic and therapeutic vacceination |
| 02/07/2001 | CN1283120A CD8 as inhibitor of cellular immune system |
| 02/07/2001 | CN1283108A I (chlamydia) protein, gene sequence and uses thereof |
| 02/07/2001 | CN1283082A Carbohydrate oxidase and use thereof in baking |
| 02/06/2001 | US6184440 Transgenic plants of altered morphology |
| 02/06/2001 | US6184439 Antisense gene systems of pollination control for hybrid seed production |
| 02/06/2001 | US6184437 Nucleotide sequences which code a polypeptide with an amino acid sequence high in lysine; for the amplification of nutritional quality of plants |
| 02/06/2001 | US6184436 Transgenic mice expressing HIV-1 in immune cells |
| 02/06/2001 | US6184435 Transgenic mouse expressing APP770-V717F |
| 02/06/2001 | US6184371 Lactoferrin receptor genes of Moraxella |
| 02/06/2001 | US6184370 Polypeptide receptor segment; for the design of agonists and antagonists to growth factor and cytokine activities |
| 02/06/2001 | US6184360 Purification of NGF |
| 02/06/2001 | US6184359 Humanized monoclonal antibody which preferentially binds lymphocyte polypeptide; for treatment of toxicity in tumor therapy; for the treatment and prevention of gastrointestinal and viral diseases |
| 02/06/2001 | US6184358 IP-10/Mig receptor designated CXCR3, antibodies, nucleic acids, and methods of use therefor |
| 02/06/2001 | US6184356 Globin protein; for amplifying oxygen carrying capacity of a blood substitute |
| 02/06/2001 | US6184354 Peptides of human macrophage colony stimulating factor binding protein; for the detection of modulators of macrophage colony stimulating factor |
| 02/06/2001 | US6184353 Method for modulating processes mediated by farnesoid activated receptors |
| 02/06/2001 | US6184352 Adseverin protein |
| 02/06/2001 | US6184351 Artificial brain protein; for the treatment of alzheimer's and parkinson's disease |
| 02/06/2001 | US6184349 Cloned peripheral nerve, tetrodotoxin-resistant sodium channel α-subunit |
| 02/06/2001 | US6184348 Genetically engineered amino acid sequences which represent duplicated oligopeptides; for the biosynthesis of preferential polypeptides |
| 02/06/2001 | US6184346 Peptide of defined amino acid sequence which inhibits elastase and subtilisin; use as drug because of low molecular weight |
| 02/06/2001 | US6184343 Fetal globin inducing factor |
| 02/06/2001 | US6184342 Amino acid sequences preferential for the modulation of granulocytes migratatory response; wound healing agents |
| 02/06/2001 | US6184208 Peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
| 02/06/2001 | US6184207 A peptide including specified piperidine-containing group, having an n-terminal hydrophobic residue and optionally an amidated c-terminal of specified end groups; treating multiple sclerosis or rheumatoid arthritis |
| 02/06/2001 | US6184206 Administering a compound which dissociates fibrinogen bound to a first site on platelet glycoprotein iib-iiia, by binding to a second interacting site of the platelet glycoprotein, disaggregating the platelet thrombus |
| 02/06/2001 | US6184205 Purified peptide of given amino acid sequences that binds to the n-terminal sh3 domain of grb2; useful in modulating signal transduction pathways at the cellular level, in modulating oncogenic protein activity |
| 02/06/2001 | US6184204 Peptides suitable for use in antigen specific immunosuppressive therapy |
| 02/06/2001 | US6184203 Low molecular weight gtp-binding proteins (lmwg); inhibiting inflammation in an individual by administering a peptide nadph oxidase inhibitor, which inhibits nadph oxidase in a cell-free assay of given content including a rac protein |
| 02/06/2001 | US6184202 Modulating apoptosis of a cell by administering an agent comprising a bh1 or bh2 domain capable of promoting or inhibiting formation of a complex of bcl-2:blc-2; bcl-xl:bcl-xl; bax:bax; and/or bcl-xl:bax |
| 02/06/2001 | US6184201 Of given amino acid sequence; use in treating disorders of the small bowel |
| 02/06/2001 | US6184200 Truncated glial cell line-derived neurotrophic factor |
| 02/06/2001 | US6184038 Transport proteins and their uses |